Home / Companies / Sutro Biopharma, Inc. / 6 Jun 2024
Sutro Biopharma, Inc.: meeting of 6 Jun 2024
Votes reported on Form N-PX, item by item
200 Form N-PX filers reported votes at the Sutro Biopharma, Inc. meeting of 6 Jun 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 61.5% of reported votes for; 50 filers withheld from or voted against at least one nominee.
291 vote records from 77 filers. 8 of the 77 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
302 vote records from 199 filers. 12 of the 193 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
146 vote records from 77 filers. 3 of the 77 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
14 vote records from 9 filers. 1 of the 9 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
132 vote records from 69 filers. 8 of the 69 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | Abstain or withhold * | For | For |
| State Street and SPDR | Split or no vote | For | For |
| American Century | Split or no vote | For | For |
| Invesco | Split or no vote | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | Split or no vote | For | For |
| John Hancock and Manulife | Abstain or withhold * | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Split or no vote | For | For |
| PGIM and Prudential | No report | For | No report |
| Jackson National funds | Abstain or withhold * | For | For |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | Split or no vote | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | Abstain or withhold * | For | For |
| Voya | Split or no vote | For | For |
| Russell Investments | For | For | For |
| Nationwide | For | For | For |
| Victory Capital | Split or no vote | For | For |
| Brighthouse Funds | Split or no vote | For | For |
| Guggenheim and Rydex | Split or no vote | For | For |
| Columbia Threadneedle | Split or no vote | For | For |
| BNY Mellon | No report | For | No report |
| Principal | Split or no vote | For | For |
| Pacific Life funds | For | For | For |
| Global X | Split or no vote | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | Split or no vote | For | For |
| Janus Henderson | No report | For | No report |
| Neuberger Berman | No report | For | No report |
| Baird | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Sutro Biopharma, Inc. meeting?
200 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 12 of 193 voted against management (6.2%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sutro Biopharma, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Sutro Biopharma, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sutro Biopharma, Inc. with a meeting date within three days of 6 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.